Lv1
30 积分 2022-11-16 加入
EXABS-185-TCL The Next Rational Therapeutic Regimen in Newly Diagnosed PTCL
1年前
已完结
Efficacy and safety of phosphatidylinositol 3-kinase inhibitors in patients with chronic lymphocytic leukemia: a meta-analysis and systematic review
2年前
已完结
ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol-3 kinase/akt activity with retained but inactivated PTEN-A report from the Children's Oncology Group
2年前
已完结
皖公网安备34019202002308
